The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03202355 |
Recruitment Status :
Terminated
(Sponsor terminated due to clinical staffing changes and enrolment)
First Posted : June 28, 2017
Last Update Posted : April 8, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Malocclusion | Device: Fixed Appliance Orthodontic Treatment Device: OrthoPulse™ | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 10 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | This is a two-arm, parallel, open-label, non-randomized, controlled, private practice study designed to evaluate the intended purposes of the investigation. |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The Effect of OrthoPulse Photobiomodulation on the Rate of Tooth Movement During Alignment With Fixed Appliances |
Actual Study Start Date : | April 20, 2017 |
Actual Primary Completion Date : | March 11, 2019 |
Actual Study Completion Date : | March 11, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: Group 1 (Control)
Subjects assigned to this group receive fixed appliance orthodontic treatment only
|
Device: Fixed Appliance Orthodontic Treatment
Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. |
Experimental: Group 2 (OP1)
Subjects assigned to this group receive fixed appliance orthodontic treatment in conjunction with receiving daily OrthoPulse™ treatments.
|
Device: Fixed Appliance Orthodontic Treatment
Patients receive fixed appliance orthodontic treatment by the qualified Principal Investigator (PI). Treatment and follow-up appointments per the traditional practices of the PI and dental office. Device: OrthoPulse™ Patients carry out daily OrthoPulse™ treatments at home. |
- Rate of tooth movement in OrthoPulse treated and non-OrthoPulse treated patients [ Time Frame: From start of treatment until Little's Irregularity Index (LII) reaches less than approximately 2 mm but greater than 0 mm, no more than 6 months after the start of treatment. ]Rate of tooth movement will be evaluated based on the duration of time and amount of tooth movement required to reach Little's Irregularity Index (LII) of less than approximately 2 mm but greater than 0 mm, as determined by the qualified investigator.
- Effect of OrthoPulse PBM on external apical root resorption (EARR) [ Time Frame: 6 months after the start of orthodontic treatment ]Root lengths from patients will be measured using panoramic radiographs at the start of treatment and 6 months after the start of treatment. These measurements will be used to determine and compare EARR between each of the two groups.
- Risk of OrthoPulse PBM to the patient. [ Time Frame: Participants will be followed for the duration of their orthodontic treatment, an expected average of 1-2 years, depending on the severity of the case ]Patients from both groups will be questioned and assessed at regularly scheduled visits for treatment-related adverse events.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 11 Years to 60 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Presence of permanent dentition
- Eligible and scheduled for full-mouth, fixed-appliance orthodontic treatment
- Moderate to severe crowding (LII ≥ 3 mm), with no labio-lingually displaced teeth
- Class I or Class II malocclusion by ½ cusp or less
- Non-extraction in both arches
- Age 11-60
- Good oral hygiene
- Non-smoker; non-use of chewing tobacco
Exclusion Criteria:
- Subject is currently enrolled in another clinical study
- Subject decided on Invisalign rather than braces
- Periodontally involved teeth
- Use of bisphosphonates (osteoporosis drugs) during the study
- Subject plans to relocate over the treatment period
- Spaces between anterior teeth
- Subject has dental implants or an implanted prosthesis
- Sponsor employees, the Investigator and staff, as well as their immediate family members

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03202355
United States, Arizona | |
Dickerson Orthodontics | |
Chandler, Arizona, United States, 85224 | |
Dickerson Orthodontics | |
Peoria, Arizona, United States, 85382 | |
Dickerson Orthodontics | |
Phoenix, Arizona, United States, 85028 |
Study Director: | Peter Brawn, DDS | Biolux Research Holdings, Inc. |
Responsible Party: | Biolux Research Holdings, Inc. |
ClinicalTrials.gov Identifier: | NCT03202355 |
Other Study ID Numbers: |
BX11 |
First Posted: | June 28, 2017 Key Record Dates |
Last Update Posted: | April 8, 2019 |
Last Verified: | April 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
Alignment phase Photobiomodulation Orthodontic treatment Malocclusion OrthoPulse™ |
Malocclusion Tooth Diseases Stomatognathic Diseases |